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INTRODUCTION:  A  primary  cancer  causing  thyroid  metastasis  is  extremely  rare.  In western  countries,  the
most  common  primary  tumors  causing  thyroid  metastases  include  kidney,  lung,  breast,  and  gastroin-
testinal  cancers.  In  contrast,  breast  is  the  most  common  primary  site,  followed  by  kidney,  colon,  and  lung
cancers  in  Korea.  To  the  best  of  our  knowledge,  surgically  conﬁrmed  thyroid  metastasis  from  cholan-
giocarcinoma  has  not  been  reported.  Herein,  we  report  the  ﬁrst  case  of  thyroid  metastasis  secondary  to
cholangiocarcinoma  on  which  surgery  was  performed.
PRESENTATION OF  CASE:  A  55-year-old  man  was  diagnosed  with  hepatic  malignancy  in December  2008.
He  subsequently  received  2 cycles  of  transarterial  chemoembolization  and  4 cycles  of  radio-frequency
ablation  between  2008  and  2010.  At  follow-up  in January  2011,  brain  metastasis  was identiﬁed  in the
right  parietal  area  secondary  to  cholangiocarcinoma.  In  April  2011,  the  patient  was  found  to  have  palpable
masses  on  the  left  thyroid  and  lateral  neck.  The  patient  subsequently  underwent  total  thyroidectomy
followed  by left  radical  neck  dissection.  Intraoperatively,  an  ill-deﬁned  mass  measuring  6.0  cm  was  found
inﬁltrating  the  subcutaneous  tissue  into  the  prevertebral  fascia.  Microscopic  and  immunohistochemical
ﬁndings  conﬁrmed  that  the thyroid  masses  and  lymph  nodes  were  metastatic  cholangiocarcinoma.
DISCUSSION: Positive  immunohistochemical  staining  for  cytokeratin  7, cytokeratin  19, and  AFP  and  neg-
ative  results  for  TG, TTF-1,  and  cytokeratin  20  can be  deﬁnitely  helpful  in  arriving  at a correct  diagnosis.
CONCLUSION:  To  the  best  of  our  knowledge,  this  is  the  ﬁrst  case  report  on  surgically  resected  thyroid  and
lateral  neck  metastases  secondary  to cholangiocarcinoma.
gical  © 2011 Sur
. Introduction
Metastasis to the thyroid gland secondary to other malignant
umors has been reported for a variety of primary tumors, but the
ondition remains extremely rare. In western countries, the most
ommon primary tumors causing thyroid metastasis include kid-
ey, lung, breast, and gastrointestinal cancers.1,2 In contrast, breast
s the most common primary site, followed by kidney, colon, and
ung cancers in Korea.3
To the best of our knowledge, surgically conﬁrmed thy-
oid metastasis from cholangiocarcinoma has not been reported.
lthough ﬁve cases of thyroid gland metastases have been reported
econdary to hepatocellular carcinoma (HCC),4–7 only one case
∗ Corresponding author at: Department of Surgery, Chonnam National University
ollege  of Medicine, 42, Jebongno, Dong-gu, Gwangju 501-757, Republic of Korea.
el.: +82 62 220 6356; fax: +82 62 227 1635.
E-mail addresses: thokthok@hanmail.net (M.H. Park), sabiston@hotmail.com
J.S. Cho).
1 Department of Surgery, Chonnam National University College of Medicine, 42,
ebongno, Dong-gu, Gwangju 501-757, Republic of Korea. Tel.: +82 62 220 6456;
ax:  +82 62 227 1635.
210-2612     ©  2011 Surgical Associates Ltd. Published by Elsevier Ltd. 
oi:10.1016/j.ijscr.2011.11.001
Open access under CC BY-Associates Ltd. Published by Elsevier Ltd. 
report has been published on thyroid metastasis secondary to
cholangiocarcinoma conﬁrmed by ﬁne needle aspiration cytology
(FNAC), which was  also reported by our institution.8 Herein, we
describe a male patient who  developed concurrent brain and thy-
roid gland metastasis secondary to cholangiocarcinoma of the liver.
2. Presentation of case
A 55-year-old man  was presumed to have hepatocellular
carcinoma and not a type of cholangiocarcinoma in December
2008. Radiological examination revealed a 1.7 cm mass in seg-
ment 5 and a 4.0 cm mass in segment 6 of the liver (Fig. 1A).
He had an elevated alpha-fetoprotein (AFP) of 2876 IU/mL
(normal range = 0–5.8 IU/mL), but normal carcinoembryonic anti-
gen (CEA; normal range = 0–4.7 ng/mL) and CA19-9 (normal
range = 0–39 U/mL) levels. He subsequently received 2 cycles of
transarterial chemoembolization (TACE) and 4 cycles of radio-
frequency ablation (RFA) between 2008 and 2010.
Open access under CC BY-NC-ND license.At  follow-up in January 2011, brain metastasis was identiﬁed
in the right parietal area, which was  assumed to be secondary
to hepatocellular carcinoma. Intraoperatively, a mass measuring
2.7 cm × 2.6 cm × 2.0 cm was conﬁrmed as cholangiocarcinoma and
NC-ND license. 
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ot hepatocellular carcinoma (Fig. 1B). No evidence of thyroid or
ateral neck metastasis was found in a physical examination, radi-
logical evaluation, and positron emission tomography (PET).
In April 2011, the patient was found to have palpable masses on
he left side of the thyroid and lateral neck. Neck ultrasonography
nd computed tomography (CT) revealed a 6.0 cm × 3.4 cm mass on
he left thyroid gland and multiple conglomerated, solid, and cys-
ic metastatic lymphadenopathies on the left lateral neck. PET/CT
howed solid and cystic lesions associated with left thyroid malig-
ancy, exhibiting high ﬂuorine-18 ﬂurodeoxyglucose (FDG) uptake
ith a maximal standardized uptake value (SUVmax) of 13.4 in the
hyroid and 10.3 in the left lateral neck with PET (Fig. 1C and D).
It was difﬁcult to discern poorly differentiated thyroid carci-
oma from metastatic liver malignancy by performing FNAC on
he thyroid. However, we have presumed metastatic cholangiocar-
inoma preoperatively on the thyroid and lateral neck, such as what
as found in the brain. The patient subsequently underwent total
hyroidectomy followed by left functional radical neck dissection.
ntraoperatively, an ill-deﬁned mass measuring 6.0 cm was found
nﬁltrating the subcutaneous tissue into the prevertebral fascia.Histopathological examination of the resected thyroid tissues
nd lymph nodes conﬁrmed moderately differentiated adenocarci-
oma (Fig. 2A), with microscopic characteristics similar to the brain
esions resected previously (Fig. 2B). Immunohistochemical studies
ig. 1. Liver MRI  shows 4.0 cm and 1.7 cm masses in the ﬁfth and sixth segment
.7  cm × 2.6 cm × 2.0 cm metastatic cholangiocarcinoma in the right parietal area of the b
holangiocarcinoma of 13.4 SUVmax in the left thyroid, isthmus, and multiple lymph nodPEN  ACCESS
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were performed and displayed strong immunoreactivity for cytok-
eratin 7 and cytokeratin 19 and were negative for cytokeratin 20,
thyroglobulin, thyroid transcription factor-1, hepatocyte-speciﬁc
antigen, and -fetoprotein (Fig. 3). Taken together, these micro-
scopic and immunohistochemical ﬁndings conﬁrmed that the
thyroid masses and lymph nodes were metastatic cholangiocar-
cinoma.
3. Discussion
The incidence of thyroid metastases caused by all tumor
types ranges between 1.9% and 9.5%.9,10 Surgically resected thy-
roid metastasis specimens constitute between 0.02 and 1.4%.11,12
Metastatic thyroid disease is found more frequently with the rou-
tine use of FNAB.3 To the best of our knowledge, only one case of
thyroid metastasis secondary to cholangiocarcinoma through the
use of FNAB has been reported.8 This is the ﬁrst case of surgically
resected thyroid metastasis due to cholangiocarcinoma.
The diagnosis of thyroid metastasis is frequently delayed
because early symptoms and signs are subtle, and symptomatic
thyroid dysfunction is rare. In patients with an oncological his-
tory of presenting with thyroid nodules, the possibility of thyroid
metastasis should always be considered. However, it may be dif-
ﬁcult to distinguish poorly differentiated thyroid carcinoma from
s of the right hepatic lobe, respectively, in December 2008 (A). CT shows a
rain in January 2011 (B). F-18 FDG PET/CT in April 2011. PET/CT shows metastatic
es in the left lateral neck (C and D).
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ther metastatic thyroid malignancies. Thus, various immunohisto-
hemical stains on pathological specimens may  facilitate diagnosis.
A limitation of this case is that histological diagnosis was
ot performed on the pre-existing liver mass by percutaneous
iver biopsy or other invasive methods. He underwent right
emicolectomy due to perforation of the hepatic ﬂexure colon dur-
ng percutaneous liver biopsy. Thus, the patient was presumed
o have HCC or cholangiocarcinoma and underwent TACE and
FA treatment. The metastatic tumors in the brain and thyroid
ere completely matched with the microscopic histopathology of
holangiocarcinomas.
Our case of thyroid metastasis due to cholangiocarcinoma
eets the criterion of histological appearance and also matches
he immunohistochemical staining proﬁle of cholangiocarcinomas.
ytokeratin 19 was positive in all cholangiocarcinomas and only
n 5% of HCCs, and TTF-1 was identiﬁed in 93% of HCCs and 10% of
holangiocarcinomas.13 In our case, positive immunohistochemical
ig. 3. Immunohistochemical features of cholangiocarcinoma metastasis to the thyroid. 
o  not express thyroid transcription factor-1 (C) and hepatocyte-speciﬁc antigen (D) (aviwed the same histological features of cholangiocarcinoma. (H&E, 100×).
staining for cytokeratin 7, cytokeratin 19, and AFP and negative
results for TG, TTF-1, and cytokeratin 20 can be deﬁnitely helpful
in arriving at a correct diagnosis.
Aggressive surgical approaches with total or subtotal thyroidec-
tomy and extensive lymph node dissection have been proposed.14
Metastasis to the thyroid is rare, but most clinicians favor surgi-
cal resection to conﬁrm the diagnosis and avoid local compressive
symptoms, such as asphyxia. To date, however, no conclusive sur-
vival advantage following surgery has been proven.2,14,15 Survival
outcome, however, is universally poor with the diagnosis of thyroid
metastasis and ranges between 1 and 12 months. The prognosis
varies with the malignancy grade of the primary lesion and the
presence of metastasis in organs other than the thyroid gland.16
Chemotherapy has traditionally been administered as palliative
treatment in this setting. Reports on chemotherapy for the treat-
ment of thyroid metastases are scant, and the use of 5-FU alone
in this setting yielded disappointing results, with survival ranging
Tumor cells characteristically express cytokeratin 7 (A) and cytokeratin 19 (B), but
din-biotin-peroxidase, 200×).
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etween 1 and 6 months.17,18 Two months after thyroidectomy
ith functional radical neck dissection, repeat CT showed local
ecurrence on the lateral neck bilaterally, for which the patient
eceived 5-FU and platinum-based systemic chemotherapy.
. Conclusion
To the best of our knowledge, this is the ﬁrst case report on
urgically resected thyroid and lateral neck metastases secondary
o cholangiocarcinoma. Although uncommon, the possibility of a
etastatic tumor involving the thyroid gland should always be
onsidered in patients with oncological history.
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